The International Stem Cell Corporation (ISCO) (OTCQB:ISCO), a clinical stage biotechnology company based in California, has announced the development of a new 3D bioprinter that produces liver tissue. The technology is suited to the liver progenitor cell (LPC) line, adding to ISCO’s existing pipeline of products including ISC-hpNSC for brain treatments, and ChondraStem to treat […]
from 3D Printing Industry
martes, 10 de octubre de 2017
5:33
MR: EDITOR
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts